Hantide Biomedical Group Co., Ltd. is a high-tech enterprise focusing on the development of synthetic biology technology. It is mainly engaged in the design, production and sales of new gene recombinant peptide drugs. The company has more than 6000 square meters of scientific research centers in Shandong, Tianjin and Jiangsu. The production bases of Gaoqing in Zibo and Lianyungang in Jiangsu cover an area of 80000 square meters. It has a first-class R & D team composed of returnees and domestic leaders, and has completed the laboratory of gene editing, enzyme engineering, high-throughput peptide synthesis, quality management and control. Based on the rational design of drugs, combined with advanced synthetic biological technology, the "green intelligent manufacture" of recombinant peptide drugs, new antibody drugs and active small molecular compounds is realized.
● Based on the principle of "complementary advantages, mutual benefits, serving local communities and common development", Hanpeptide Biomedical Group Co., Ltd. and Shandong University reached an agreement on long-term cooperation bet
● A platform for the research and development of recombinant polypeptide drugs and a screening platform for novel anti-tumor drugs were established, and the fermentation technology of polyglutamic acid and antialcoholic bacteria was established
● Jiangsu Hanpeptide Biomedicine Co., LTD., registered by Hanpeptide Biomedicine Group Co., LTD., is located in Donghai County, Lianyungang, the bridgehead of the beautiful and rich Eurasian continent.The company's business scope includes
● In 2020, it signed a strategic cooperation agreement with Chuangzhigu, Huantai County, Zibo city, to prepare for the construction of biological laboratory and the development of light medical beauty production line, medical equipment, health
● At the beginning of 2020, the company signed a cooperation agreement with Gaoqing Economic Development Zone of Zibo, planning to build polypeptide API production lines, polyglutamic acid and hyaluronic acid production lines, etc.
Based on the principle of "complementary advantages, mutual benefit, serving local communities and common development", Shandong Hanpeptide[2020-08-14]
On May 28, 2020, "Shandong Hanpeptide Biomedicine Co., LTD. - Shandong University Research and Development Team Cooperation Exchange Meeting"[2020-08-14]
版权所有 © 汉肽生物医药集团 鲁ICP备069573500456号
Scan follows the public account